New Stent Technology for Heart Disease
Author Information
Author(s): Haddad Raymond N., Bonnet Damien, Alsac Jean-Marc, Malekzadeh-Milani Sophie
Primary Institution: M3C-Necker, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
Hypothesis
Can the Optimus-CVS stent improve outcomes in congenital heart disease interventions?
Conclusion
Optimus-CVS appears to be a reliable high-performing alternative for treating congenital heart disease.
Supporting Evidence
- The Optimus-CVS stent was successfully implanted in three patients.
- Procedures were straightforward with minimal stent shortening.
- No stent failures were recorded during short-term follow-up.
Takeaway
A new type of stent called Optimus-CVS is being tested to help kids with heart problems, and it seems to work really well.
Methodology
Three patients with congenital heart disease received the Optimus-CVS stent during December 2020, and their outcomes were assessed.
Limitations
The maximum available length of the stent may be short for some procedures, and there are concerns about aneurysms at the stent extremities.
Participant Demographics
Three patients with congenital heart disease, including a 20-year-old female, a 31-year-old male, and a 33-year-old female.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website